Medical Device News Magazine

2.5mm MicroStent and MicroBalloon XL Receive CE Mark Reports Micro Medical Solutions

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Summation

  • MMS is currently engaged in an FDA randomized, multicenter pivotal clinical study for MicroStent, called STAND (A Clinical Evaluation of the MicroSTent PeripherAl Vascular SteNt in subjects with Arterial Disease Below the Knee), which began in May 2020 and will continue this year at up to 25 sites across the U.

2.5mm MicroStent and MicroBalloon XL have received the CE Mark. The news was announced today by Micro Medical Solutions.

2.5 mm MicroStent vascular stent, the smallest diameter MicroStent to date has received the CE Mark. The news was announced today by Micro Medical Solutions. Also granted CE Mark approval is the long (150 cm) over-the-wire balloon catheter, MicroBalloon XL. The MicroStent and MicroBalloon are part of the MMS Micro Vascular Integrated Platform (mVIP), designed to achieve and maintain vessel patency and improve blood flow in order to reduce below-the-knee amputations for patients with critical limb ischemia (CLI) resulting from peripheral artery disease (PAD).

“We’re very pleased to receive CE Mark approval for both the 2.5 mm MicroStent and 150 cm MicroBalloon XL,” said Micro Medical Solutions CEO Gregory Sullivan. “By expanding our portfolio of interventional devices, we are broadening the base of patients with CLI whom we can treat to avoid a life-altering below-the-knee amputation.”

Already available in diameters of 3.0-4.5 mm, MicroStent can now be used in vessels as small as 2.5 mm, all available in lengths of 8 mm, 15 mm, 25 mm, 40 mm and 60 mm. Diabetes, a common comorbidity of PAD and CLI, may cause patients to have smaller blood vessels requiring a smaller stent. The addition of a longer 150 cm MicroBalloon XL to the MicroBalloon line (40, 60, 80, and 100 mm) makes it possible for surgeons to take a contralateral or ipsilateral approach to treatment, expanding their options beyond a pedal approach. Greater flexibility permits surgeons to choose the wisest entry point and customize the equipment to each patient’s needs.

Designed for effective, efficient treatment of CLI resulting from PAD, the mVIP suite of devices has previously been CE Mark approved in both a 3Fr. and 4Fr. delivery system, providing the least invasive approach for patients. MMS is currently engaged in an FDA randomized, multicenter pivotal clinical study for MicroStent, called STAND (A Clinical Evaluation of the MicroSTent PeripherAl Vascular SteNt in subjects with Arterial Disease Below the Knee), which began in May 2020 and will continue this year at up to 25 sites across the U.S. MicroBalloon has FDA 510(k) clearance. In addition, the MMS study HEAL (An All-Comers Observational Study of the MicroStent Peripheral Vascular Stent System in Subjects With Peripheral Arterial Disease) is currently enrolling patients at centers in the EU. 


1. Henry AJ, Hevelone ND, Belkin M, Nguyen LL. Socioeconomic and hospital-related predictors of amputation for critical limb ischemia. J Vasc Surg. 2011 Feb;53(2):330-9.e1.

2. Baser O, Verpillat P, Gabriel S, et al. Prevalence, incidence, and outcomes of critical limb ischemia in the US Medicare population. Vasc Dis Mgmt. 2013:10;E26-36.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in Suspected Coronary Artery Disease

The HeartFlow Plaque Analysis uses proprietary algorithms to analyze coronary CT angiogram (CCTA) scans, creating a personalized 3D model that quantifies and characterizes plaque volume in the coronary arteries, aiding risk assessment of coronary artery disease. The technology was introduced at the Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting in Washington, D.C.

Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

Recognizing each individual’s health journey is unique, PowerPlugs enable people to choose and focus on the aspects of their health that matter most. It’s designed for highly personalized health insights, ensuring that every individual can personalize their health tracking to their unique needs and goals.

VisionAir Solutions Celebrates Milestone and New Collaboration

This achievement marks VisionAir Solutions commitment to bringing technological innovation to pulmonary medicine. Since its acquisition by Theken Companies last year, VAS has over doubled its growth and continues to demonstrate industry adoption and the advantages of personalized healthcare.